Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
4.040
+0.040 (1.00%)
At close: Jul 21, 2026, 4:00 PM EDT
3.700
-0.340 (-8.42%)
After-hours: Jul 21, 2026, 7:34 PM EDT
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $96.12 million as of July 21, 2026. Its market cap has increased by 115.04% in one year.
Market Cap
96.12M
Enterprise Value
-7.34M
1-Year Change
115.04%
Ranking
Category
Stock Price
$4.04
ChartMarket Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $96.12M, a decrease of -55.19%. That is a compound annual growth rate of -45.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 96.12M | -39.11% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 90.39M |
| Heron Therapeutics | 90.10M |
| Inovio Pharmaceuticals | 89.68M |
| Rallybio | 88.80M |
| NeurAxis | 85.33M |
| Adicet Bio | 84.95M |
| Champions Oncology | 84.71M |
| NeOnc Technologies Holdings | 84.54M |